Hot Products

Cyclo(Pro-Trp)
Catalog No: CFN90277

Cyclo(Pro-Trp) and cyclo(Phe-Pro) show broad spectrum antibacterial properties.

Cyclo(Pro-Val)
Catalog No: CFN90275

Cyclo(Pro-Val) shows cyctoxic, moderate antifungal and weak antitumor activities in vitro, it can inhibit the growth of Bacillus subtilis with the minimal inhibitory concentration (MIC) value of 0.8 g/L. Cyclo(Pro-Val) and cyclo(Pro-Tyr) are toxic to both suspension cells and seedlings of Pinus thunbergii, which may offer some clues to research the mechanism of pine wilt disease caused by pine wood nematode.

Cyclo(Tyr-Hpro)
Catalog No: CFN90279

Reference standards.

Cyclo(Tyr-Leu)
Catalog No: CFN90287

Cyclo(Tyr-Leu) shows cytotoxicity, antifungal,and anticoagulant activities.

Cyclo(Tyr-Phe)
Catalog No: CFN90278

Cyclo-(Phe-Tyr) shows anticoagulant activities.

Cyclo(Tyr-Pro)
Catalog No: CFN90276

Cyclo(Tyr-Pro) shows antibacterial activity towards several marine bacterial species, it also shows weak antagonistic activity against VEGFR2 -CD. Cyclo(Tyr-Pro) and cyclo(Pro-Val) are toxic to both suspension cells and seedlings of Pinus thunbergii, which may offer some clues to research the mechanism of pine wilt disease caused by pine wood nematode.

Cyclo(Tyr-Val)
Catalog No: CFN90268

Reference standards.

Cycloartanol
Catalog No: CFN97994

Cycloartanol is a natural product from Citrus medica.

Cycloartenyl ferulate
Catalog No: CFN91779

Cycloartenyl ferulate possesses several biological activities including anti-oxidative activity, antiallergic activity, anti-inflammatory and anticancer activities.

Cycloastragenol
Catalog No: CFN99538

Cycloastragenol has been shown to extend T cell proliferation by increasing telomarase activity showing that it may also help delay the onset of cellular aging; it is an extraordinary wound healing agent; it inhibits the apoptosis of PC12 induced by 6-OHDA, may be as potential neuroprotective agents in the treatment of Parkinson's disease. Cycloastragenol and astragaloside IV can suppress ROS-associated ER stress and then inhibit TXNIP/NLRP3 inflammasome activation with regulation of AMPK activity, and thereby ameliorate endothelial dysfunction by inhibiting inflammation and reducing cell apoptosis. Cycloastragenol and astragaloside IV have been shown to improve the proliferative response of CD8+ T lymphocytes from HIV-infected patients by upregulating telomerase activity, they also may exert their cellular effects through the activation of the Src/MEK/ERK pathway.